These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 39038108)

  • 1. Small Scale, Big Impact: Nanotechnology-Enhanced Drug Delivery for Brain Diseases.
    Miao K; Xia X; Zou Y; Shi B
    Mol Pharm; 2024 Aug; 21(8):3777-3799. PubMed ID: 39038108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advances in nanocarriers enabled brain targeted drug delivery across blood brain barrier.
    Sharma G; Sharma AR; Lee SS; Bhattacharya M; Nam JS; Chakraborty C
    Int J Pharm; 2019 Mar; 559():360-372. PubMed ID: 30721725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular and Molecular Targeted Drug Delivery in Central Nervous System Cancers: Advances in Targeting Strategies.
    Zhao X; Ye Y; Ge S; Sun P; Yu P
    Curr Top Med Chem; 2020; 20(30):2762-2776. PubMed ID: 32851962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advances in Targeted Drug Delivery Approaches for the Central Nervous System Tumors: The Inspiration of Nanobiotechnology.
    Meng J; Agrahari V; Youm I
    J Neuroimmune Pharmacol; 2017 Mar; 12(1):84-98. PubMed ID: 27449494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blood-brain barrier receptors and transporters: an insight on their function and how to exploit them through nanotechnology.
    Moura RP; Martins C; Pinto S; Sousa F; Sarmento B
    Expert Opin Drug Deliv; 2019 Mar; 16(3):271-285. PubMed ID: 30767695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanobiotechnology-based drug delivery in brain targeting.
    Dinda SC; Pattnaik G
    Curr Pharm Biotechnol; 2013; 14(15):1264-74. PubMed ID: 24910011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Active Targeting Towards and Inside the Brain based on Nanoparticles: A Review.
    Rabiei M; Kashanian S; Samavati SS; Jamasb S; McInnes SJP
    Curr Pharm Biotechnol; 2020; 21(5):374-383. PubMed ID: 31793421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multifunctional Nanocarriers for diagnostics, drug delivery and targeted treatment across blood-brain barrier: perspectives on tracking and neuroimaging.
    Bhaskar S; Tian F; Stoeger T; Kreyling W; de la Fuente JM; Grazú V; Borm P; Estrada G; Ntziachristos V; Razansky D
    Part Fibre Toxicol; 2010 Mar; 7():3. PubMed ID: 20199661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanotech revolution for the anti-cancer drug delivery through blood-brain barrier.
    Caraglia M; De Rosa G; Salzano G; Santini D; Lamberti M; Sperlongano P; Lombardi A; Abbruzzese A; Addeo R
    Curr Cancer Drug Targets; 2012 Mar; 12(3):186-96. PubMed ID: 22268384
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Applications of nanotechnology in drug delivery to the central nervous system.
    Saeedi M; Eslamifar M; Khezri K; Dizaj SM
    Biomed Pharmacother; 2019 Mar; 111():666-675. PubMed ID: 30611991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanoscale drug delivery systems and the blood-brain barrier.
    Alyautdin R; Khalin I; Nafeeza MI; Haron MH; Kuznetsov D
    Int J Nanomedicine; 2014; 9():795-811. PubMed ID: 24550672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Strategies for transporting nanoparticles across the blood-brain barrier.
    Zhang TT; Li W; Meng G; Wang P; Liao W
    Biomater Sci; 2016 Feb; 4(2):219-29. PubMed ID: 26646694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug Delivery to the Brain across the Blood-Brain Barrier Using Nanomaterials.
    Tsou YH; Zhang XQ; Zhu H; Syed S; Xu X
    Small; 2017 Nov; 13(43):. PubMed ID: 29045030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Noninvasive nanoparticle strategies for brain tumor targeting.
    Sun C; Ding Y; Zhou L; Shi D; Sun L; Webster TJ; Shen Y
    Nanomedicine; 2017 Nov; 13(8):2605-2621. PubMed ID: 28756093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evolving Drug Delivery Strategies to Overcome the Blood Brain Barrier.
    Hersh DS; Wadajkar AS; Roberts N; Perez JG; Connolly NP; Frenkel V; Winkles JA; Woodworth GF; Kim AJ
    Curr Pharm Des; 2016; 22(9):1177-1193. PubMed ID: 26685681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective drug delivery approaches to lesioned brain through blood brain barrier disruption.
    Al-Ahmady ZS
    Expert Opin Drug Deliv; 2018 Apr; 15(4):335-349. PubMed ID: 29466890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanobiotechnology-based drug delivery to the central nervous system.
    Jain KK
    Neurodegener Dis; 2007; 4(4):287-91. PubMed ID: 17627131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanotechnologies: a strategy to overcome blood-brain barrier.
    De Rosa G; Salzano G; Caraglia M; Abbruzzese A
    Curr Drug Metab; 2012 Jan; 13(1):61-9. PubMed ID: 22292810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brain Targeting Nanomedicines: Pitfalls and Promise.
    Kakinen A; Jiang Y; Davis TP; Teesalu T; Saarma M
    Int J Nanomedicine; 2024; 19():4857-4875. PubMed ID: 38828195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blood-brain barrier: emerging trends on transport models and new-age strategies for therapeutics intervention against neurological disorders.
    Alajangi HK; Kaur M; Sharma A; Rana S; Thakur S; Chatterjee M; Singla N; Jaiswal PK; Singh G; Barnwal RP
    Mol Brain; 2022 Jun; 15(1):49. PubMed ID: 35650613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.